Company intelligence / Profile preview

Ceragenix Pharmaceuticals, Inc.

Denver, Colorado, United Statesen.wikipedia.org ↗

Ownership: Private
Development stage: Commercial

Overview

Developed EpiCeram, a topical non-steroidal skin care cream for atopic dermatitis. Their Ceragenin compounds showed promising in vitro activity against various pathogens including antibiotic-resistant bacteria.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Small moleculesTopical creams
Industry: Biotech

Drug pipeline

2 assets

EpiCeram

1 more asset in the full pipeline.

Request access →

Partnerships

Dr. Reddy's LaboratoriesMegapharm

Beyond the preview

Go deeper on Ceragenix Pharmaceuticals, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ceragenix Pharmaceuticals, Inc..

Explore the full profile